Correlation Between Centessa Pharmaceuticals and 91324PEQ1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and 91324PEQ1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and 91324PEQ1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and UNH 53 15 FEB 30, you can compare the effects of market volatilities on Centessa Pharmaceuticals and 91324PEQ1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of 91324PEQ1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and 91324PEQ1.

Diversification Opportunities for Centessa Pharmaceuticals and 91324PEQ1

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Centessa and 91324PEQ1 is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and UNH 53 15 FEB 30 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UNH 53 15 and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with 91324PEQ1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UNH 53 15 has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and 91324PEQ1 go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and 91324PEQ1

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 11.64 times more return on investment than 91324PEQ1. However, Centessa Pharmaceuticals is 11.64 times more volatile than UNH 53 15 FEB 30. It trades about 0.06 of its potential returns per unit of risk. UNH 53 15 FEB 30 is currently generating about -0.16 per unit of risk. If you would invest  1,551  in Centessa Pharmaceuticals PLC on October 6, 2024 and sell it today you would earn a total of  150.00  from holding Centessa Pharmaceuticals PLC or generate 9.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.39%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  UNH 53 15 FEB 30

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
UNH 53 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UNH 53 15 FEB 30 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 91324PEQ1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Centessa Pharmaceuticals and 91324PEQ1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and 91324PEQ1

The main advantage of trading using opposite Centessa Pharmaceuticals and 91324PEQ1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, 91324PEQ1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 91324PEQ1 will offset losses from the drop in 91324PEQ1's long position.
The idea behind Centessa Pharmaceuticals PLC and UNH 53 15 FEB 30 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk